AbbVie, Inc. (ABBV)

210.26 +3.79 (+1.84%) USD  |  NYSE  |  Apr 14, 16:00
208.55 -1.71 (-0.81%) Pre-Market: 07:47
More

AbbVie FCF to Assets (TTM)

FCF to Assets (TTM) Chart

View FCF to Assets (TTM) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View FCF to Assets (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

FCF to Assets (TTM) Range, Past 5 Years

View FCF to Assets (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

FCF to Assets (TTM) Benchmarks

View FCF to Assets (TTM) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade